ArticleBone marrow transplantation2021

Allogeneic hematopoietic cell transplantation (allo-HCT) outcomes in myeloma patients on renal replacement therapy: a report from the Chronic Malignancy Working Party (CMWP) of the European Society of Blood and Marrow Transplantation (EBMT).

Meral Beksac et al.PubMed ↗Publisher ↗

No numbers read from the abstract.